Top Markets
Coin of the day
Invivyd, Inc. Invivyd, Inc.

Invivyd, Inc.

IVVD
Rangering i aksjer #17262
Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development... Adagio Therapeutics, Inc., a biopharmaceutical firm in its clinical development phase, operates within the United States, specializing in the discovery, progression, and marketing of antibody-derived solutions for infectious diseases. The company's leading drug candidate, ADG20 (adintrevimab), is a neutralizing antibody currently undergoing Phase 3 clinical investigation for both the management and prevention of coronavirus disease. Adagio Therapeutics maintains collaborative agreements with Adimab, LLC to facilitate the identification and enhancement of its exclusive antibodies. Furthermore, it partners with the Scripps Research Institute to conduct studies aimed at uncovering potential vaccine solutions for the prophylaxis, detection, or therapy of influenza or beta coronaviruses. Incorporated in 2020, the company's base of operations is in Waltham, Massachusetts.
Aksjekurs
$0.8799
Sist synkronisert: 2026-09-01
Markedsverdi
$259.22M
Endring (1 dag)
-7.85%
Endring (1 år)
-14.57%
Land
US
Handel Invivyd, Inc. (IVVD)

Kategori

Aksjeprishistorikk for Invivyd, Inc. (IVVD)
Høyeste sluttskurs: $0.88 den 2026-09-01

Laveste sluttskurs: $27.68 den 2021-08-01
Aksjeprishistorikk for Invivyd, Inc. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -37.39%
2025 355.72%
2024 -79.42%
2023 46.08%
2022 -91.63%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$553.36 37.99%
US
$1.06K 49.97%
NL
$155.59 543.18%
US
$122.21 -10.03%
AU
$762.65 8.90%
CH